HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gillette

This article was originally published in The Rose Sheet

Executive Summary

Revised net sales in 1999 and 2000 down nearly 1% to $9.07 bil. and $9.23 bil., respectively, due to changes made to comply with findings of Emerging Issues Task Force of Financial Accounting Standards Board. New accounting procedures change the way some companies account for coupons, rebates and other incentives in income statements (1"The Rose Sheet" Feb. 12, p. 15). For Gillette, sales promotion and advertising under "selected" selling, general and administrative expenses will be reduced. Gillette originally reported sales of $9.3 bil. for 2000 (2"The Rose Sheet" Jan. 29, p. 7)

You may also be interested in...



Coupon Accounting Adjustment Revenue Impact Cited To Analysts

Pharmaceutical and consumer products firms are beginning to report the financial effects of accounting procedures that change the way some companies account for coupons, rebates and other incentives in income statements.

Gillette Mach3 Sales Boost In Q4 Provides Momentum For CEO Kilts

Gillette's Mach3 men's razor and blade record 38% sales increase in the fourth quarter provides momentum for newly appointed CEO James Kilts to build an era of "sustained, profitable growth" after he assumes the helm of the firm Feb. 12.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009130

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel